autologous anti-CD19 CAR-expressing T lymphocytes UF-KURE19

{
  "id": "MLC-T-ONC-011367",
  "term": "autologous anti-CD19 CAR-expressing T lymphocytes UF-KURE19",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that have been genetically modified and transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) that targets the human tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 CAR-expressing T lymphocytes UF-KURE19 bind to and induce selective toxicity against CD19-expressing tumor cells. The CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.",
  "synonyms": [
    "UF-KURE19 CAR T cells",
    "autologous anti-CD19 CAR T cells UF-KURE19"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-cd19-car-expressing-t-lymphocytes-uf-kure19/"
}